TP53 and cancer: As expected, TP53 was the most altered gene in the studied cancers, however, RRM2B amplifications did not always significantly co-occur with TP53. Interestingly, most cases with TP53 mutations (which were missense, and truncating mutations) did not have RRM2B amplifications (Supplementary Figure 1A).